This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of biologically active molecules. It serves as a key intermediate in the creation of compounds targeting specific enzymes or receptors, often in the context of drug discovery for diseases such as cancer or inflammatory disorders. Its structure, featuring a bromoindazole moiety, makes it valuable for further functionalization through cross-coupling reactions, enabling the development of diverse therapeutic agents. Additionally, the tetrahydro-2H-pyran protecting group enhances its stability during synthetic processes, facilitating its use in complex multi-step reactions.